Morikawa Naoto

Affiliation and department：

Research field (2)： Tumor diagnostics and therapeutics , Tumor biology

Research theme for competitive and other funds (1)：

2015 - 2016 ヒト肺癌における変異型EGFRの分子シミュレーション解析に基づく個別化治療

Papers (21)：

Takashina T, Asahina H, Oizumi S, Yamada N, Harada M, Takamura K, Yokouchi H, Harada T, Honjo O, Ogi T, et al. A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101). International journal of clinical oncology. 2018. 23. 6. 1060-1069
Satoru Nihei, Junya Sato, Toshiyuki Harada, Shoichi Kuyama, Toshiro Suzuki, Nobutsugu Waga, Yoshitaka Saito, Shigeki Kisara, Atsuko Yokota, Kouji Okada, et al. Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumab. Cancer chemotherapy and pharmacology. 2018. 81. 6. 1051-1059
Sato, Junya, Morikawa, Naoto, Chiba, Ryosuke, Nihei, Satoru, Moriguchi, Satoshi, Saito, Heisuke, Yamauchi, Kohei, Kudo, Kenzo. Case series on the association between blood levels and side effects of afatinib maleate. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2017. 80. 3. 545-553
Naoto Morikawa, Akira Inoue, Shunichi Sugawara, Makoto Maemondo, Toshiyuki Harada, Masao Harada, Yuka Fujita, Terufumi Katoh, Hiroshi Yokouchi, Hiroshi Watanabe, et al. Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naIve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901. LUNG CANCER. 2017. 111. 38-42
Toshiyuki Harada, Toraji Amano, Tomoo Ikari, Kei Takamura, Takahiro Ogi, Toshiaki Fujikane, Yuka Fujita, Kageaki Taima, Hisashi Tanaka, Takaaki Sasaki, et al. Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials. Frontiers in pharmacology. 2017. 8. 972-972

ｍore...

MISC (2)：

SATO Eizaburo, WATANABE Hiroshi, MORIKAWA Naoto, UBUKATA Satoshi, SHOJI Makoto, TAKAHASHI Hiroshi. A case of transfusion-related acute lung injury (TRALI) induced by anti-HLA antibody. J. Jpn. Soc. Intern. Med. 2011. 100. 2. 491-493
森川直人, 渡辺洋. Therapy-related pulmonary toxicity. 綜合臨床. 2010. 59. 2. 311-315

Education (2)：

2005 - 2013 Tohoku University Faculty of Medicine
1993 - 2001 Hamamatsu University School of Medicine Faculty of Medicine School of Medicine

Professional career (1)：

医学博士 (東北大学)

Work history (6)：

2018/06 - 現在 Iwate medical university
2016/07 - 2018/06 UT MD Anderson cancer center Thoracic, head & neck medical oncology department Visiting scientist
2015/04 - 2016/06 Iwate Medical University School of Medicine
2013/04 - 2015/03 Iwate Medical University School of Medicine
2005/04 - 2013/03 Tohoku University

Show all

Awards (2)：

2015/04 - 日本対がん協会リレーフォーライフマイオンコロジードリーム奨励賞
2005/12 - 日本肺癌学会第46回総会優秀ポスター賞非喫煙女性の肺腺癌症例のEGFR mutation と臨床的特徴の検討

Association Membership(s) (5)：

American Society of clinical Oncology , 日本緩和医療学会 , 日本臨床腫瘍学会 , THE JAPANESE RESPIRATORY SOCIETY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page